U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C7H11NO4S
Molecular Weight 205.232
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TELMESTEINE

SMILES

CCOC(=O)N1CSC[C@H]1C(O)=O

InChI

InChIKey=XBJWOGLKABXFJE-YFKPBYRVSA-N
InChI=1S/C7H11NO4S/c1-2-12-7(11)8-4-13-3-5(8)6(9)10/h5H,2-4H2,1H3,(H,9,10)/t5-/m0/s1

HIDE SMILES / InChI

Description

Telmesteine, a mucoactive agent with strong anti-inflammatory properties. Telmesteine was used in the treatment of respiratory tract disorders. This compound inhibits elastase and collagenase and may be useful in the treatment of skin aging and psoriasis. The anti-inflammatory properties of telmesteine are mediated by blocking PI3K/Akt/IKK activities. Thus, telmesteine can be used as a potent anti-inflammatory agent for skin inflammatory and anti-inflammatory materials in cosmetics,

Approval Year

Unknown
139594
Targets

Targets

Primary TargetPharmacologyConditionPotency
PI3K/Akt/IKK signaling pathway
1
Target ID: PI3K/Akt/IKK signaling pathway
Sources: DOI: 10.1039/C7RA01111C
Inhibitor
8297
PubMed

PubMed

TitleDatePubMed
[Telemestein and variations in blood concentrations of lipoprotein A].
1994 Oct
Absorption, distribution, metabolism and excretion of telmesteine, a mucolitic agent, in rat.
2003 Jul
Name Type Language
TELMESTEINE
INCI   INN   MART.   WHO-DD  
INCI   INN  
Official Name English
TELMESTEINE [MART.]
Common Name English
TELMESTEINE [INCI]
Common Name English
REOLASE
Brand Name English
Telmesteine [WHO-DD]
Common Name English
telmesteine [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C74536
Created by admin on Fri Dec 15 16:37:54 GMT 2023 , Edited by admin on Fri Dec 15 16:37:54 GMT 2023
Code System Code Type Description
MESH
C091508
Created by admin on Fri Dec 15 16:37:54 GMT 2023 , Edited by admin on Fri Dec 15 16:37:54 GMT 2023
PRIMARY
NCI_THESAURUS
C74550
Created by admin on Fri Dec 15 16:37:54 GMT 2023 , Edited by admin on Fri Dec 15 16:37:54 GMT 2023
PRIMARY
FDA UNII
124I3FE35T
Created by admin on Fri Dec 15 16:37:54 GMT 2023 , Edited by admin on Fri Dec 15 16:37:54 GMT 2023
PRIMARY
INN
6573
Created by admin on Fri Dec 15 16:37:54 GMT 2023 , Edited by admin on Fri Dec 15 16:37:54 GMT 2023
PRIMARY
SMS_ID
100000082462
Created by admin on Fri Dec 15 16:37:54 GMT 2023 , Edited by admin on Fri Dec 15 16:37:54 GMT 2023
PRIMARY
RXCUI
85929
Created by admin on Fri Dec 15 16:37:54 GMT 2023 , Edited by admin on Fri Dec 15 16:37:54 GMT 2023
PRIMARY RxNorm
CAS
122946-43-4
Created by admin on Fri Dec 15 16:37:54 GMT 2023 , Edited by admin on Fri Dec 15 16:37:54 GMT 2023
PRIMARY
EVMPD
SUB10873MIG
Created by admin on Fri Dec 15 16:37:54 GMT 2023 , Edited by admin on Fri Dec 15 16:37:54 GMT 2023
PRIMARY
EPA CompTox
DTXSID60153804
Created by admin on Fri Dec 15 16:37:54 GMT 2023 , Edited by admin on Fri Dec 15 16:37:54 GMT 2023
PRIMARY
DRUG CENTRAL
2582
Created by admin on Fri Dec 15 16:37:54 GMT 2023 , Edited by admin on Fri Dec 15 16:37:54 GMT 2023
PRIMARY
PUBCHEM
65946
Created by admin on Fri Dec 15 16:37:54 GMT 2023 , Edited by admin on Fri Dec 15 16:37:54 GMT 2023
PRIMARY
ChEMBL
CHEMBL2107621
Created by admin on Fri Dec 15 16:37:54 GMT 2023 , Edited by admin on Fri Dec 15 16:37:54 GMT 2023
PRIMARY
ACTIVE MOIETY
Structure of TELMESTEINE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966